Tatsuya Ando

6PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2023
Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced Nephrotoxicity.

Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando

|May 22, 2023
CD8+ Regulatory T Cells Induced by Lipopolysaccharide Improve Mouse Endotoxin Shock.

Nanaka Morita, Masato Hoshi, Hiroyuki Tezuka

|May 10, 2023
Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced Nephrotoxicity.

Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando

|Mar 27, 2023
Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice.

Daisuke Ito, Hiroyasu Ito, Tatsuya Ando

|Jun 24, 2022
Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma.

Ryota Yamagishi, Fumitaka Kamachi, Masaru Nakamura

|Jun 29, 2021
3-Hydroxykynurenine Regulates Lipopolysaccharide-Stimulated IL-6 Production and Protects against Endotoxic Shock in Mice.

Masato Hoshi, Hisako Kubo, Tatsuya Ando

Pageof 1

Frequent Collaborators

2 joint publications

Masato Hoshi

2 joint publications

Kuniaki Saito

2 joint publications

Honomi Ando

2 joint publications

Hidetsugu Fujigaki